36C77019Q0597-003.pdf
PDF 134 KB Posted
- Attached to
- Geo-Med Federal contract opportunity
- Solicitation number
- 36C77019Q0597
About this file
36C77019Q0597 P03-PM_Part813.106_Atcht1_SingleSourceJustification_MPT-SAT-Redacted.pdf
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| -17250.docx | DOCX document | |
| 36C77019Q0597-002.xlsx | XLSX spreadsheet | |
| 36C77019Q0597-001.docx | DOCX document | |
| 36C77019Q0597-000.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
VHAPM Part 813.106 Simplified Acquisition Procedures: Soliciting from a Single Source Attachment 1: Single Source Justification for SAP under the SAT
VHAPM Part 813.106 Page 1 of 1 Original Date: 08/30/17 Revision 01 Eff Date: 04/23/2018
DEPARTMENT OF VETERANS AFFAIRS
Justification for Single Source Awards IAW FAR 13.106-1 For
Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)
Acquisition Plan Action ID:_____36770-19-AP-0746_________________
1. Contracting Activity: Department of Veterans Affairs, Supplies will be purchased for the CMOP Leavenworth. 760-19-4-050-1783
2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount:
Product requested by the VA Medical Ctrs the Leavenworth 760 CMOP serves
3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used:
Products have been prescribed for patients by VA Physicians. Pharmacy employees do not have the training and/or authority to countermand physician orders. “Brand Specific” products are the same thing as “dispense as written” on a physician prescription. No NDC substitutions are permitted. In the VA, Pharmacy Benefits Management (PBM) has determined that CMOP IDs in the National Drug File (NDF) will most always identify “brand specific” products in the VA PRINT NAME. This is not always inclusive where a particular NDC has been determined to be “formulation specific” by clinical evaluation performed by the PBM or in the case where only one product in the marketplace has been identified to contain the specific ingredients to match the product code.
4. Description of market research conducted and results or statement why it was not conducted:
Products were searched in the NAC and GSA catalog and none of the items were found to be on contract.
5. Contracting Officer's Certification: Purchase is approved in accordance with FAR13.106-1(b). I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.
Joetta M. Eagle Date Contracting Officer
Joetta M. Eagle 399755 Digitally signed by Joetta M. Eagle 399755 Date: 2019.07.01 13:44:20 -05'00'
File details come from the government source that posted it.